Product Information

EPLERENONE 50 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.4714 per EA under NDC 59762110801. Its NADAC has been published 92 times since Feb 12, 2025.

FDA first approved this application on Sep 27, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the eplerenone market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

EPLERENONE 50 MG TABLET

eplerenone
$0.4714per EA
Low Outlier

Strength

50 mg/1

NDC

59762110801

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

EPLERENONE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021437

FDA Approved

9/27/2002

TE Code

AB

On Market Since

11/14/2024

Pharmacological Classes

Aldosterone Antagonist
Aldosterone Antagonists

Price Statistics

The NADAC for EPLERENONE 50 MG TABLET has been published 92 times since Feb 12, 2025, and over the history we have for it it has declined 11.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4714 per EA
All-time high$0.6037 (May 14, 2025)
All-time low$0.4504 (Sep 23, 2026)
52-week high$0.4967
52-week low$0.4504
Median price$0.4958
Average price$0.5056
Largest weekly change+8.8% (Feb 19, 2025)
Weeks tracked92
Tracking sinceFeb 12, 2025

Price History

1W

0.0%

1M

+4.7%

3M

+3.4%

6M

-0.3%

1Y

-9.3%

3Y

N/A

5Y

N/A

All

-11.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 1%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EPLERENONE 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for EPLERENONE 50 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.4714 per EA (NDC 59762110801), effective Nov 11, 2026.

How has the price of EPLERENONE 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for EPLERENONE 50 MG TABLET has declined 11.3%. It has been tracked across 92 weekly CMS publications since Feb 12, 2025.

What are the highest and lowest recorded NADAC prices for EPLERENONE 50 MG TABLET?

Since Feb 12, 2025, the NADAC for EPLERENONE 50 MG TABLET has ranged from a low of $0.4504 (Sep 23, 2026) to a high of $0.6037 (May 14, 2025), with a median of $0.4958 per EA.

Are there cheaper alternatives to EPLERENONE 50 MG TABLET?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPLERENONE 50 MG TABLET, is $0.4659 per EA — about 1% below EPLERENONE 50 MG TABLET.

Who manufactures EPLERENONE 50 MG TABLET?

EPLERENONE 50 MG TABLET (NDC 59762110801) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.